Patents Assigned to John R. A. Simoons
  • Treatment of rheumatoid arthritis and related diseases
    Patent number: 4426384
    Abstract: It is believed that rheumatoid arthritis and related collagen and auto-immune diseases are an infection and that various species of free-living (limax) amoebae are the aetiological agent of these diseases. It has been discovered that pyrimidines with anti-protozoal activity, are effective for the treatment of rheumatoid arthritis and other collagen and auto-immune (rheumatoid) diseases.
    Type: Grant
    Filed: August 5, 1982
    Date of Patent: January 17, 1984
    Assignee: John R. A. Simoons
    Inventor: Roger Wyburn-Mason
  • Treatment of rheumatoid arthritis and related diseases
    Patent number: 4402965
    Abstract: It is believed that rheumatoid arthritis and related collagen and auto-immune diseases are an infection and that various species of free-living (limax) amoebae are the aetiological agent of these diseases. It has been discovered that furazolidone is effective for the treatment of rheumatoid arthritis and other collagen and auto-immune (rheumatoid) diseases.
    Type: Grant
    Filed: August 5, 1982
    Date of Patent: September 6, 1983
    Assignee: John R. A. Simoons
    Inventor: Roger Wyburn-Mason
  • Treatment of rheumatoid arthritis and related diseases
    Patent number: 4218449
    Abstract: It is believed that rheumatoid arthritis and related collagen and auto-immune diseases are an infection and that various species of free-living (limax) amoebae are the aetiological agent of these diseases. It has been discovered that certain nitroimidazole compounds, anti-mycotic drugs with anti-protozoal activity, are effective for the treatment of rheumatoid arthritis and other collagen and auto-immune (rheumatoid) diseases.
    Type: Grant
    Filed: March 8, 1979
    Date of Patent: August 19, 1980
    Assignee: John R. A. Simoons
    Inventor: Roger Wyburn-Mason
  • Treatment of rheumatoid arthritis and related diseases
    Patent number: 4183941
    Abstract: It is believed that rheumatoid arthritis and related collagen and auto-immune diseases are an infection and that various species of free-living (limax) amoebae are the aetiological agent of these diseases. It has been discovered that certain nitroimidazole compounds, anti-mycotic drugs with anti-protozoal activity, are effective for the treatment of rheumatoid arthritis and other collagen and auto-immune (rheumatoid) diseases.
    Type: Grant
    Filed: August 21, 1978
    Date of Patent: January 15, 1980
    Assignee: John R. A. Simoons
    Inventor: Roger Wyburn-Mason
  • Treatment of rheumatoid arthritis and related diseases
    Patent number: 4119723
    Abstract: It is believed that rheumatoid arthritis and related collagen and auto-immune diseases are an infection and that various species of free-living (limax) amoebae are the aetiological agent of these diseases. It has been discovered that tinidazole and related compounds, antimycotic drugs with anti-protozoal activity, are effective for the treatment of rheumatoid arthritis and other collagen and auto-immune (rheumatoid) diseases.
    Type: Grant
    Filed: July 8, 1977
    Date of Patent: October 10, 1978
    Assignee: John R. A. Simoons
    Inventor: Roger Wyburn-Mason
  • Treatment of rheumatoid arthritis and related diseases
    Patent number: 4073922
    Abstract: It is believed that rheumatoid arthritis and related collagen and auto-immune diseases are an infection and that various species of free-living (limax) amoebae are the aetiological agent of these diseases. It has been discovered that clotrimazole bis-phenyl (2-chlorphenyl)-1-imidazolyl-methane! and related compounds, antimycotic drugs with anti-protozoal activity, are effective for the treatment of rheumatoid arthritis and other collagen and auto-immune (rheumatoid) diseases.
    Type: Grant
    Filed: June 29, 1976
    Date of Patent: February 14, 1978
    Assignee: John R. A. Simoons
    Inventor: Roger Wyburn-Mason